Vyome Holdings (HIND) EBITDA Margin (QoQ) (2015 - 2026)
Vyome Holdings (HIND) EBITDA Margin (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.59 Bn | 131.73 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.21 Bn | 78.22 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.65 Bn | 60.47 Bn | 1.37 Bn |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - |
| 10 | Vyome Holdings | 16.00 Mn | 8.11 Mn | 11,658.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 37,676.00 |
| Mar 31, 2026 | 13,057.00 |
| Dec 31, 2025 | 2.11 Mn |
| Sep 30, 2025 | -2.45 Mn |
| Jun 30, 2025 | -12,217.00 |
| Mar 31, 2025 | 31,655.00 |
| Dec 31, 2024 | -8,434.00 |
| Sep 30, 2024 | -22,789.00 |
| Jun 30, 2024 | 915.00 |
| Mar 31, 2024 | -1,807.00 |
| Dec 31, 2023 | 8,444.00 |
| Sep 30, 2023 | -365.00 |
| Jun 30, 2023 | 6,982.00 |
| Mar 31, 2023 | 29,053.00 |
| Dec 31, 2022 | -9,712.00 |
| Sep 30, 2022 | -12,000.00 |
| Jun 30, 2022 | 1,286.00 |
| Sep 30, 2021 | -28,433.00 |
| Jun 30, 2021 | -3,446.00 |
| Mar 31, 2021 | 2,984.00 |